pCVL Traffic Light Reporter 1.1 (Sce target) Ef1a Puro Citations (24)
Originally described in: Tracking genome engineering outcome at individual DNA breakpoints.Certo MT, Ryu BY, Annis JE, Garibov M, Jarjour J, Rawlings DJ, Scharenberg AM Nat Methods. 2011 Jul 10;8(8):671-6. doi: 10.1038/nmeth.1648. PubMed Journal
Articles Citing pCVL Traffic Light Reporter 1.1 (Sce target) Ef1a Puro
Showing 1 to 10 of 24 entries
| Articles |
|---|
Articles |
|---|
| Chromatin-Associated SIN3B Protects Cancer Cells from Genotoxic Stress-Induced Apoptosis and Dictates DNA Damage Repair Pathway Choice. Morales-Valencia J, Petit C, Calderon A, Saini S, David G. Mol Cancer Res. 2023 Sep 1;21(9):947-957. doi: 10.1158/1541-7786.MCR-22-0466. PubMed |
| Functional characterization of C21ORF2 association with the NEK1 kinase mutated in human in diseases. Gregorczyk M, Pastore G, Munoz I, Carroll T, Streubel J, Munro M, Lis P, Lange S, Lamoliatte F, Macartney T, Toth R, Brown F, Hastie J, Pereira G, Durocher D, Rouse J. Life Sci Alliance. 2023 May 15;6(7):e202201740. doi: 10.26508/lsa.202201740. Print 2023 Jul. PubMed |
| A non-canonical, interferon-independent signaling activity of cGAMP triggers DNA damage response signaling. Banerjee D, Langberg K, Abbas S, Odermatt E, Yerramothu P, Volaric M, Reidenbach MA, Krentz KJ, Rubinstein CD, Brautigan DL, Abbas T, Gelfand BD, Ambati J, Kerur N. Nat Commun. 2021 Oct 27;12(1):6207. doi: 10.1038/s41467-021-26240-9. PubMed |
| 5'-Modifications improve potency and efficacy of DNA donors for precision genome editing. Ghanta KS, Chen Z, Mir A, Dokshin GA, Krishnamurthy PM, Yoon Y, Gallant J, Xu P, Zhang XO, Ozturk AR, Shin M, Idrizi F, Liu P, Gneid H, Edraki A, Lawson ND, Rivera-Perez JA, Sontheimer EJ, Watts JK, Mello CC. Elife. 2021 Oct 19;10. pii: 72216. doi: 10.7554/eLife.72216. PubMed |
| Eliminating hypoxic tumor cells improves response to PARP inhibitors in homologous recombination-deficient cancer models. Mehibel M, Xu Y, Li CG, Moon EJ, Thakkar KN, Diep AN, Kim RK, Bloomstein JD, Xiao Y, Bacal J, Saldivar JC, Le QT, Cimprich KA, Rankin EB, Giaccia AJ. J Clin Invest. 2021 Jun 1;131(11). pii: e146256. doi: 10.1172/JCI146256. PubMed |
| A Validated Functional Analysis of Partner and Localizer of BRCA2 Missense Variants for Use in Clinical Variant Interpretation. Brnich SE, Arteaga EC, Wang Y, Tan X, Berg JS. J Mol Diagn. 2021 Jul;23(7):847-864. doi: 10.1016/j.jmoldx.2021.04.010. Epub 2021 May 6. PubMed |
| A subset of PARP inhibitors induces lethal telomere fusion in ALT-dependent tumor cells. Mukherjee J, Pandita A, Kamalakar C, Johannessen TC, Ohba S, Tang Y, Dalle-Ore CL, Bjerkvig R, Pieper RO. Sci Transl Med. 2021 May 5;13(592). pii: 13/592/eabc7211. doi: 10.1126/scitranslmed.abc7211. PubMed |
| The dystonia gene THAP1 controls DNA double-strand break repair choice. Shinoda K, Zong D, Callen E, Wu W, Dumitrache LC, Belinky F, Chari R, Wong N, Ishikawa M, Stanlie A, Multhaupt-Buell T, Sharma N, Ozelius L, Ehrlich M, McKinnon PJ, Nussenzweig A. Mol Cell. 2021 Jun 17;81(12):2611-2624.e10. doi: 10.1016/j.molcel.2021.03.034. Epub 2021 Apr 14. PubMed |
| CAM-Delam: an in vivo approach to visualize and quantify the delamination and invasion capacity of human cancer cells. Palaniappan TK, Slekiene L, Jonasson AK, Gilthorpe J, Gunhaga L. Sci Rep. 2020 Jun 26;10(1):10472. doi: 10.1038/s41598-020-67492-7. PubMed |
| Phosphoglycerate Mutase 1 Activates DNA Damage Repair via Regulation of WIP1 Activity. Ohba S, Johannessen TA, Chatla K, Yang X, Pieper RO, Mukherjee J. Cell Rep. 2020 Apr 14;31(2):107518. doi: 10.1016/j.celrep.2020.03.082. PubMed |
If you have published an article using this material, please email us at help@addgene.org to have your article added to this page.